Analysts Viewpoint
Goldman’s latest rating for TARS stock
Tarsus Pharmaceuticals Inc’s recent filing unveils that its President/CEO and Board Chair Azamian Bobak R. unloaded Company’s shares for reported
Tarsus Pharmaceuticals Inc’s recent filing unveils that its President/CEO and Board Chair Azamian Bobak R. unloaded Company’s shares for reported
Tarsus Pharmaceuticals Inc’s recent filing unveils that its President/CEO and Board Chair Azamian Bobak R. unloaded Company’s shares for reported
In a filing, Tarsus Pharmaceuticals Inc revealed its President/CEO and Board Chair Azamian Bobak R. unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Tarsus Pharmaceuticals Inc’s filing revealed that its President/CEO and Board Chair Azamian Bobak R. unloaded Company’s shares for reported $0.32